MENU
+Compare
MLSS
Stock ticker: ASE
AS OF
Dec 23, 04:52 PM (EDT)
Price
$0.89
Change
-$0.04 (-4.30%)
Capitalization
47.46M

MLSS Milestone Scientific Forecast, Technical & Fundamental Analysis

a provider of subcutaneous injection technology for dental and medical applications

MLSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for MLSS with price predictions
Dec 20, 2024

MLSS sees MACD Histogram crosses below signal line

MLSS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 13, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MLSS moved out of overbought territory on December 02, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLSS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MLSS broke above its upper Bollinger Band on November 26, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MLSS entered a downward trend on November 25, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where MLSS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 20, 2024. You may want to consider a long position or call options on MLSS as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

MLSS moved above its 50-day moving average on December 20, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MLSS crossed bullishly above the 50-day moving average on December 03, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where MLSS advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MLSS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.807) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.755) is also within normal values, averaging (43.338).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
MLSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MLSS is expected to report earnings to fall 50.00% to 0 cents per share on April 07

Milestone Scientific MLSS Stock Earnings Reports
Q4'24
Est.
$-0.01
Q3'24
Est.
$-0.02
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.02
Q4'23
Missed
by $0.01
The last earnings report on November 15 showed earnings per share of -1 cents, meeting the estimate of -1 cents. With 39.47K shares outstanding, the current market capitalization sits at 47.46M.
A.I. Advisor
published General Information

General Information

a provider of subcutaneous injection technology for dental and medical applications

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
425 Eagle Rock Avenue
Phone
+1 973 535-2717
Employees
20
Web
https://www.milestonescientific.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZO3253.4738.18
+1.19%
AutoZone
EGHT2.720.03
+1.12%
8x8
VRE16.410.03
+0.18%
Veris Residential
SWX69.650.08
+0.11%
Southwest Gas Holdings
NTRB4.08-0.19
-4.45%
Nutriband

MLSS and Stocks

Correlation & Price change

A.I.dvisor tells us that MLSS and SRDX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and SRDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
+16.05%
SRDX - MLSS
26%
Poorly correlated
-0.40%
VTAK - MLSS
25%
Poorly correlated
+0.92%
ACRS - MLSS
24%
Poorly correlated
-1.81%
BLFS - MLSS
24%
Poorly correlated
+4.90%
ARAY - MLSS
24%
Poorly correlated
+3.35%
More